← Leaderboards
Sergio A. Giralt
University Of Texas Md Anderson Can Ctr
$6,224,032
Attributed
$6,224,032
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $477.1K · FY2005–23$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,224,032 · 7
By mechanism
P01$3,308,877 · 4
U01$1,789,842 · 2
U10$1,125,313 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionPreventRecurrenceRelapseImmuneTransplantationClinical TrialsToxic EffectHematopoietic Stem CellsPrevention StrategyAllogenicPharmaceutical PreparationsProgramsConditioningChronic Graft Versus Host DiseaseProphylactic TreatmentCd34 GeneFutureHematologic NeoplasmsCellsEventRandomizedT-Cell DepletionAcute
Grant awards (28)
Project 6: Clinical Trials Focusing on Microbiota and Novel Cell Therapies$393,942
P01 · FY2023 · CA · contact PI
Project 6: Clinical Trials Focusing on Microbiota and Novel Cell Therapies$386,125
P01 · FY2022 · CA · contact PI
Project 6: Clinical Trials Focusing on Microbiota and Novel Cell Therapies$389,409
P01 · FY2021 · CA · contact PI
Project 6: Clinical Trials Focusing on Microbiota and Novel Cell Therapies$4,030
P01 · FY2021 · CA · contact PI
Project 6: Clinical Trials Focusing on Microbiota and Novel Cell Therapies$393,942
P01 · FY2020 · CA · contact PI
Project 6: Clinical Trials Focusing on Microbiota and Novel Cell Therapies$8,561
P01 · FY2020 · CA · contact PI
Project 6: Clinical Trials Focusing on Microbiota and Novel Cell Therapies$393,942
P01 · FY2019 · CA · contact PI
MSKCC BMT CTN Renewal$189,302
U10 · FY2016 · HL · contact PI
MSKCC BMT CTN Renewal$189,302
U10 · FY2015 · HL · contact PI
MSKCC BMT CTN Renewal$189,302
U10 · FY2014 · HL · contact PI
MSKCC BMT CTN Renewal$189,302
U10 · FY2013 · HL · contact PI
PREVENTING THERAPY-INDUCED SYMPTOMS IN MULTIPLE MYELOMA PATIENTS$287,783
P01 · FY2012 · CA · contact PI
MSKCC BMT CTN Renewal$189,302
U10 · FY2012 · HL · contact PI
PREVENTING THERAPY-INDUCED SYMPTOMS IN MULTIPLE MYELOMA PATIENTS$270,010
P01 · FY2011 · CA · contact PI
MSKCC BMT CTN Renewal$178,803
U10 · FY2011 · HL · contact PI
PREVENTING THERAPY-INDUCED SYMPTOMS IN MULTIPLE MYELOMA PATIENTS$299,317
P01 · FY2010 · CA · contact PI
IL-7 FOR IMMUNE RECOVERY AFTER HEMATOPOIETIC ALLOGRAFTS$168,259
U01 · FY2010 · HL · contact PI
PREVENTING THERAPY-INDUCED SYMPTOMS IN MULTIPLE MYELOMA PATIENTS$294,801
P01 · FY2009 · CA · contact PI
IL-7 FOR IMMUNE RECOVERY AFTER HEMATOPOIETIC ALLOGRAFTS$65,783
U01 · FY2009 · HL · contact PI
PREVENTING THERAPY-INDUCED SYMPTOMS IN MULTIPLE MYELOMA PATIENTS$187,015
P01 · FY2008 · CA · contact PI
Blood Marrow Transplant Clinical Trials Research Network$1
U01 · FY2008 · HL · contact PI
Blood Marrow Transplant Clinical Trials Research Network$1
U01 · FY2007 · HL · contact PI
Blood Marrow Transplant Clinical Trials Research Network$155,000
U01 · FY2006 · HL · contact PI
Reduced intensity vs myeloablative conditioning for old*$35,798
U01 · FY2006 · HL · contact PI
Reduced intensity vs myeloablative conditioning for old*$405,000
U01 · FY2005 · HL
Reduced intensity vs myeloablative conditioning for old*$405,000
U01 · FY2004 · HL
Reduced intensity vs myeloablative conditioning for old*$150,000
U01 · FY2003 · HL
Reduced intensity vs myeloablative conditioning for old*$405,000
U01 · FY2002 · HL